| Trial ID: | L0865 |
| Source ID: | NCT02568605
|
| Associated Drug: |
Prebiotic
|
| Title: |
Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Prebiotic fibre;Dietary Supplement: Placebo;Behavioral: Weight Loss
|
| Outcome Measures: |
Change in Liver Fat;Change in Liver Fibrosis;Change in Liver InjuryChange in Glucose Tolerance;Change in Glycemic Control;Change in Subjective Appetite;Change in Satiety Hormones;Change in Body Composition;Change in Quality of Life;Dietary Adherence;Examine mechanisms related to prebiotic-induced changes in gut microbiota, their metabolic byproducts, and de novo lipogenesis
|
| Sponsor/Collaborators: |
University of Calgary
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
|
| Start Date: |
30/09/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
10 May 2021
|
| Locations: |
Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT02568605
|
